An approach to stabilize PBS-based formulations could provide a simple physiological solution for use of proteins in research, preclinical, diagnostics, and clinical studies, as well as commercial biotherapeutic products.
Zahra Shahrokh
Advertisement
Articles by Zahra Shahrokh
This study offers a strategy for stabilization of biotherapeutics for long-term frozen storage in PBS-based formulations.
The study demonstrates a systematic approach to stabilize PBS-formulated mAbs against freeze-thaw degradation.
Achieving multiproduct development within shortened timelines.
Advertisement
Latest Updated Articles
Efficient Multiproduct Process Development Case StudyPublished: August 1st 2011 | Updated:
Enabling Freeze-Thaw Stability of PBS-Based Formulations of a Monoclonal AntibodyPublished: August 1st 2016 | Updated:
Part II: Enabling Freeze-Thaw Stability of PBS-Based Formulations of a Monoclonal AntibodyPublished: September 1st 2016 | Updated:
Enabling Freeze-Thaw Stability of PBS-Based Formulations of a Monoclonal Antibody Part III: Effect of Glass Transition TemperaturePublished: October 1st 2016 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Meeting Global Demand and Delivering Faster, More Reliable Service
2
A Strategic Assessment Tool for Modernizing Buffer Preparation in Biologics Facilities
3
Streamlining Procurement and Inventory Management Leads to Increased Productivity
4
Outsourcing Small Molecule Purification Processes
5
